Interrogating both DNA and RNA, the OncoExTra test provides ultra-comprehensive genomic profiling that thoroughly detects clinically actionable mutations and fusions.1
It delivers the all-encompassing genomic insights of whole-exome (DNA) and whole-transcriptome* (RNA) sequencing, highlighting key information that is critical to personalized cancer care.
The OncoExTra test may be right for
your patient whose cancer is:
‡IHC testing not currently available in New York State
MSI, microsatellite instability; TMB, tumor mutational burden